Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02800486
Title Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwell Health
Indications

glioblastoma

anaplastic astrocytoma

mixed glioma

Therapies

Cetuximab

Age Groups: adult
Covered Countries USA


No variant requirements are available.